218 related articles for article (PubMed ID: 27626174)
1. Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma.
Wang L; Dong H; Ni S; Huang D; Tan C; Chang B; Sheng W
Oncotarget; 2016 Oct; 7(43):69749-69759. PubMed ID: 27626174
[TBL] [Abstract][Full Text] [Related]
2. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.
Chan AW; Tong JH; Sung MY; Lai PB; To KF
Histopathology; 2014 Nov; 65(5):674-83. PubMed ID: 24804938
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
[TBL] [Abstract][Full Text] [Related]
6. Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection.
Tsai JH; Liau JY; Lee CH; Jeng YM
Am J Surg Pathol; 2021 Oct; 45(10):1409-1418. PubMed ID: 33859071
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China.
Sun K; Xu S; Wei J; Wang B; Owusu-Ansah KG; Wang W; Wu J; Zheng S
Medicine (Baltimore); 2016 Oct; 95(40):e5069. PubMed ID: 27749575
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein-Barr virus: Two cases report.
Ling W; Lu C; Huang H; Qiu T; Lu Q; Huang C; Gong P; Luo Y; Chen S
Medicine (Baltimore); 2019 Jan; 98(3):e14206. PubMed ID: 30653176
[TBL] [Abstract][Full Text] [Related]
9. The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
Yang Q; Cai Q; Wen H; Mao Y; Ban X; Rong D; Zhang R
AJR Am J Roentgenol; 2021 Feb; 216(2):393-402. PubMed ID: 33325732
[No Abstract] [Full Text] [Related]
10. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor.
Jeng YM; Chen CL; Hsu HC
Am J Surg Pathol; 2001 Apr; 25(4):516-20. PubMed ID: 11257627
[TBL] [Abstract][Full Text] [Related]
11. Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablation.
Nogami A; Saito S; Hasegawa H; Yoneda M; Harada K; Fujikawa H
Clin J Gastroenterol; 2021 Apr; 14(2):638-644. PubMed ID: 33400192
[TBL] [Abstract][Full Text] [Related]
12. An EBV+ lymphoepithelioma-like cholangiocarcinoma in a young woman with chronic hepatitis B.
Gearty SV; Al Jurdi A; Pittman ME; Gupta R
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31289161
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression in extrahepatic cholangiocarcinoma.
Walter D; Herrmann E; Schnitzbauer AA; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2017 Sep; 71(3):383-392. PubMed ID: 28419539
[TBL] [Abstract][Full Text] [Related]
14. Epstein
Peng L; Peng X; Duan S; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):319-330. PubMed ID: 38755729
[TBL] [Abstract][Full Text] [Related]
15. Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review.
Sam Saji A; Yang B; Hou WT; Liu X; Ren QP; Wei YF; Zhang YZ; Yang X
Front Oncol; 2023; 13():1090580. PubMed ID: 36865802
[TBL] [Abstract][Full Text] [Related]
16. Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma.
Gani F; Nagarajan N; Kim Y; Zhu Q; Luan L; Bhaijjee F; Anders RA; Pawlik TM
Ann Surg Oncol; 2016 Aug; 23(8):2610-7. PubMed ID: 27012989
[TBL] [Abstract][Full Text] [Related]
17. Lymphoepithelioma-like cholangiocarcinoma (LELC) not associated with Epstein-Barr virus.
Szekely E
Am J Surg Pathol; 2001 Nov; 25(11):1464-6. PubMed ID: 11684969
[No Abstract] [Full Text] [Related]
18. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
Dong Z; Liao B; Shen W; Sui C; Yang J
Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
[TBL] [Abstract][Full Text] [Related]
19. Lymphoepithelioma-like neoplasm of the biliary tract with 'probable low malignant potential'.
Khandakar B; Liu JR; Thung S; Li Y; Rhee H; Kagen AC; Sun-Wing Tong T; Nyun Park Y; Theise N; Oi-Lin Ng I
Histopathology; 2022 Mar; 80(4):720-728. PubMed ID: 34608670
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case.
Aosasa S; Maejima T; Kimura A; Nishiyama K; Edo H; Shinmoto H; Kaji T; Ogata S; Hatsuse K; Hase K; Yamamoto J
Int Surg; 2015 Apr; 100(4):689-95. PubMed ID: 25875552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
